Page last updated: 2024-11-04

2-(4-methyl-1,3-thiazol-5-yl)ethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(4-methyl-1,3-thiazol-5-yl)ethanol: the thiazole portion of thiamine; imparts flavor to cooked meats; RN given is for parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-(2-hydroxyethyl)-4-methylthiazole : A 1,3-thiazole that is thiazole substituted by a methyl group at position 4 and a 2-hydroxyethyl group at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1136
CHEMBL ID1236482
CHEBI ID17957
SCHEMBL ID259480
MeSH IDM0059687

Synonyms (98)

Synonym
CHEMBL1236482 ,
CHEBI:17957 ,
2-(4-methyl-1,3-thiazol-5-yl)ethanol
nsc41831
nsc-41831
4-methyl-5-(.beta.-hydroxyethyl)thiazole
nsc-23262
4-methyl-5-hydroxyethylthiazole
4-methyl-5-thiazoleethanol
MHT ,
nsc23262
hemineurine
4-methyl-5-thiazolethanol
5-(hydroxyethyl)-4-methylthiazole
5-thiazoleethanol, 4-methyl-
2-(4-methylthiazol-5-yl)ethanol
2-(4-methyl-thiazol-5-yl)-ethanol
TZE ,
4-methyl-5-(2-hydroxyethyl)-thiazole
4-methyl-5-(beta-hydroxyethyl)thiazole
5-(2-hydroxyethyl)-4-methylthiazole
137-00-8
4-methyl-5-(2'-hydroxyethyl)-thiazole
HET ,
C04294
4-methyl-5-(2-hydroxyethyl)thiazole
4-methyl-5-thiazoleethanol, >=98%, fg
4-methyl-5-hydroxethylthiazole
DB02969
sulfurol
4-methyl-5-thiazoleethanol, 98%
inchi=1/c6h9nos/c1-5-6(2-3-8)9-4-7-5/h4,8h,2-3h2,1h
48114B6F-A59B-4E5B-82B1-38B17D2A0B5A
AC-7852
thiazole, 4-methyl-5-hydroxyethyl-
2-(4-methylthiazole-5-yl)ethanol
4-methyl-5-thiazolylethanol
5-(beta-hydroxyethyl)-4-methylthiazole
BMSE000355
thiamine thiazole
mht (van)
4-methyl-5-(beta-hydroxyethyl)-thiazole
H0527
AKOS000119411
2-(4-methyl-1,3-thiazol-5-yl)ethan-1-ol
nsc 23262
nsc 41831
unii-3xyv4i47i8
ai3-23391
einecs 205-272-6
3xyv4i47i8 ,
fema no. 3204
NCGC00257545-01
dtxsid3044382 ,
dtxcid1024382
cas-137-00-8
tox21_302187
thiamine thiozole
FT-0608672
PS-4466
AM20080272
860175-16-2
AB00407
4-methyl-5-thiazoleethanol [fhfi]
2-(4-methyl-5-thiazolyl)ethanol
5-(.beta.-hydroxyethyl)-4-methylthiazole
4-methyl-5-thiazole ethanol [fcc]
4-methyl-5-thiazoleethanol [mi]
4-methyl-5-thiazole ethanol
SCHEMBL259480
2-(4-methylthiazol-5-yl)-ethanol
5-(2-hydroxyethyl)-4-methyl-1,3-thiazole
5-(2-hydroxyethyl)-4-methyl-thiazole
2-(4-methylthiazol-5-yl) ethanol
4-methyl-5-thiazole-ethanol
STR05522
4-methylthiazol-5ylethanol
bdbm50016817
Q-100145
2-(4-methyl-1,3-thiazol-5-yl)ethanol #
thiazole, 5-(2-hydroxyethyl)-4-methyl
mfcd00005339
4-methyl-5-hydroxyethyl thiazole
4-methyl-5-thiazoleethanol, analytical standard
5-(2-hydroxyethyl)-4-methylthiazole; mht
5-(2-hydroxyethyl)-4-methylthiazole (sulfurol)
4-metyl-5-(beta-hydroxyethyl)thiazole
fema 3204
4-methyl-5-thiazoleethanol, 9ci
CS-W016411
Q27093940
D77790
4-methyl-5-thiazoleethanol; sulfurol; 4-methyl-5-(2'-hydroxyethyl)-thiazole; 4-methyl-5-hydroxyethylthiazole; 5-(2-hydroxyethyl)-4-methylthiazole; 4-methyl-5-beta-hydroxyethyl thiazole
HY-W015695
clomethiazole impurity c
EN300-20333
PD007492
Z104477768

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" We show that the toxic effect of this drug is relieved by low concentrations of thiamine (Th) and that the pyrimidine moiety of the Th molecule is responsible for growth inhibition release."( Amiloride toxicity in the fission yeast Schizosaccharomyces pombe is released by thiamine and mutations in the thiamine-repressible gene car1.
Edenharter, E; Fankhauser, H; Niederberger, C; Schweingruber, ME, 1996
)
0.29

Bioavailability

ExcerptReferenceRelevance
" To provide proof of concept for the nomethiazole drug class, selected examples were assayed for restoration of synaptic function in hippocampal slices from AD-transgenic mice, reversal of cognitive deficits, and brain bioavailability of the prodrug and its neuroprotective MZ metabolite."( Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy.
Arancio, O; Fa', M; Luo, J; Qin, Z; Tavassoli, E; Teich, AF; Thatcher, GR; VandeVrede, L, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
1,3-thiazoles
primary alcoholA primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (11)

PathwayProteinsCompounds
Vitamin B1/Thiamine Metabolism819
thiamine salvage IV (yeast)415
thiamine formation from pyrithiamine and oxythiamine (yeast)015
thiamine salvage II011
thiamine diphosphate salvage IV (yeast)015
thiamine salvage IV (yeast)417
thiamine formation from pyrithiamine and oxythiamine (yeast)317
thiamine salvage II928
4-methyl-5(u03B2-hydroxyethyl)thiazole salvage110
thiamin salvage IV917
thiamin formation from pyrithiamine and oxythiamine317
thiamin salvage II011
4-methyl-5(u03B2-hydroxyethyl)thiazole salvage (yeast)28
Thiamin biosynthesis117

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
progesterone receptorHomo sapiens (human)Potency68.58960.000417.946075.1148AID1346784
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency17.37390.023723.228263.5986AID743223
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)Ki4,669.00000.00121.25638.9000AID1147919; AID1147920; AID1147921; AID1147922
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1147919Competitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 7 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
AID703708Neuroprotective activity against oxygen-glucose deprivation-induced toxicity in Sprague-Dawley rat primary cortical neurons at 50 uM incubated for 2 hrs prior to oxygen-glucose deprivation-challenge measured after 24 hrs by MTT assay relative to clomethia2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy.
AID1147920Noncompetitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 7 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
AID1147921Competitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 8.25 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
AID1147922Noncompetitive inhibition of electric eel AChE using acetylthiocholine chloride as substrate at pH 8.25 by Michaelis-Menten plot analysis1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Inhibition of acetylcholinesterase by thiamine. A structure-function study.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's5 (31.25)18.2507
2000's1 (6.25)29.6817
2010's6 (37.50)24.3611
2020's2 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.57 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]